Review of Helicobacter pylori eradication regimens

Scandinavian Journal of Gastroenterology, Supplement

Volumn 31, Issue 215, 1996, Pages 74-81

  Unge, P ^a  

^a Sandviken Animal Hospital   (Sweden)

Author keywords

Efficacy; Eradication regimens; Helicobacter pylori; Intention to treat analysis; Meta analysis; Study quality; Success rates; Treatment classes

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; MACROLIDE; NITROIMIDAZOLE DERIVATIVE; OMEPRAZOLE; ANTIINFECTIVE AGENT; ANTIULCER AGENT; BISMUTH;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; ERADICATION THERAPY; GASTRITIS; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; PRIORITY JOURNAL; ARTICLE; DRUG COMBINATION; HELICOBACTER INFECTION;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BISMUTH; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; OMEPRAZOLE;

EID: 0029948554     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609094541     Document Type: Conference Paper

References (2)

1. Adamek RJ, Freitag M, Opferkuch W, Rühl GH, Wegener M. Duration of therapy plays a decisive role in H. pylori eradication using omeprazole and amoxicillin. Am J Gastroenterol 1994;89:1362.
2. Adamek RJ, Freitag M, Opferkuch W, Rühl GH, Wegener M. Intravenous omeprazole/amoxicillin and omeprazole pretreatment in Helicobacter pylori-positive acute peptic ulcer bleeding. Scand J Gastroenterol 1994;29:880-3.